CellaVision AB
STO:CEVI
CellaVision AB
Long-Term Debt
CellaVision AB
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellaVision AB
STO:CEVI
|
Long-Term Debt
kr12.7m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Long-Term Debt
kr5.9B
|
CAGR 3-Years
15%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
S
|
Surgical Science Sweden AB
STO:SUS
|
Long-Term Debt
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Getinge AB
STO:GETI B
|
Long-Term Debt
kr8.3B
|
CAGR 3-Years
33%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Long-Term Debt
kr3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Long-Term Debt
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
What is CellaVision AB's Long-Term Debt?
Long-Term Debt
12.7m
SEK
Based on the financial report for Dec 31, 2024, CellaVision AB's Long-Term Debt amounts to 12.7m SEK.
What is CellaVision AB's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
-37%
Over the last year, the Long-Term Debt growth was -56%. The average annual Long-Term Debt growth rates for CellaVision AB have been -49% over the past three years , -37% over the past five years .
You don't have any saved screeners yet